Irradiated fields spared Stevens-Johnson syndrome in a patient undergoing radiotherapy for bone metastases

[1]  M. Lacouture,et al.  Temporal dependence of the effect of radiation on erlotinib-induced skin rash. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Simcock,et al.  Erlotinib induced skin rash spares skin in previous radiotherapy field. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  K. Devi,et al.  Carbamazepine--the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years. , 2005, Indian journal of dermatology, venereology and leprology.

[4]  M. Yoshita,et al.  MRI of segmental zoster paresis , 2005, Neurology.

[5]  M. L. del Valle,et al.  A man whose scapula was spared a drug-associated rash , 2005, Canadian Medical Association Journal.

[6]  B. Vincenzi,et al.  Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  I. Durán,et al.  Toxic Epidermal Necrolysis in Patients Receiving Anticonvulsants and Cranial Irradiation: A Risk to Consider , 2004, Journal of Neuro-Oncology.

[8]  R. Holcombe,et al.  Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine. , 2003, Anti-cancer drugs.

[9]  J. Roujeau,et al.  SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. , 2000, The Journal of investigative dermatology.

[10]  L. Wilton,et al.  Stevens-Johnson syndrome and antiepileptics , 1999, The Lancet.

[11]  L. Naldi,et al.  Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study , 1999, The Lancet.

[12]  R. Tigelaar,et al.  Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital. , 1999, Journal of the American Academy of Dermatology.

[13]  C. Belka,et al.  Impact of localized radiotherapy on blood immune cells counts and function in humans. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  J. Roujeau,et al.  Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis , 1996, The British journal of dermatology.

[15]  Mecdermot He,et al.  Huxley's Centenary. , 1925 .

[16]  Lars E French,et al.  Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[17]  B. Vincenzi,et al.  Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient , 2004 .

[18]  R. Stern,et al.  Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. , 1999, Lancet.

[19]  J. Gõmez Orbaneja,et al.  [Toxic epidermal necrolysis]. , 1967, Revista clinica espanola.